Simplex Trading’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,435
| Closed | -$58.2K | – | 8934 |
|
|
2025
Q4 | $65K | Buy |
+2,435
| New | +$58.2K | ﹤0.01% | 5409 |
|
|
2025
Q3 | – | Sell |
-18,631
| Closed | -$441K | – | 8928 |
|
|
2025
Q2 | $401K | Sell |
18,631
-63,318
| -77% | -$1.18M | ﹤0.01% | 3744 |
|
|
2025
Q1 | $1.36M | Buy |
81,949
+71,406
| +677% | +$1.3M | ﹤0.01% | 2408 |
|
|
2024
Q4 | $193K | Buy |
+10,543
| New | +$170K | ﹤0.01% | 4551 |
|
|
2024
Q3 | – | Sell |
-47,110
| Closed | -$786K | – | 8337 |
|
|
2024
Q2 | $765K | Sell |
47,110
-10,266
| -18% | -$166K | ﹤0.01% | 3196 |
|
|
2024
Q1 | $1.06M | Sell |
57,376
-2,989
| -5% | -$74.1K | ﹤0.01% | 3057 |
|
|
2023
Q4 | $1.89M | Sell |
60,365
-19,023
| -24% | -$454K | ﹤0.01% | 2411 |
|
|
2023
Q3 | $1.65M | Buy |
+79,388
| New | +$2.16M | ﹤0.01% | 2242 |
|
|
2023
Q1 | – | Sell |
-5,300
| Closed | -$101K | – | 8873 |
|
|
2022
Q4 | $84K | Sell |
5,300
-9,502
| -64% | -$149K | ﹤0.01% | 5278 |
|
|
2022
Q3 | $242K | Buy |
14,802
+9,502
| +179% | +$154K | ﹤0.01% | 4367 |
|
|
2022
Q2 | $74K | Sell |
5,300
-11,800
| -69% | -$220K | ﹤0.01% | 5965 |
|
|
2022
Q1 | $414K | Sell |
17,100
-69,293
| -80% | -$1.68M | ﹤0.01% | 4085 |
|
|
2021
Q4 | $2.02M | Buy |
86,393
+35,041
| +68% | +$705K | ﹤0.01% | 2045 |
|
|
2021
Q3 | $1.27M | Buy |
51,352
+200
| +0.4% | +$3.85K | ﹤0.01% | 2751 |
|
|
2021
Q2 | $1.25M | Sell |
51,152
-39,705
| -44% | -$896K | ﹤0.01% | 2797 |
|
|
2021
Q1 | $2.34M | Buy |
90,857
+69,239
| +320% | +$3.05M | ﹤0.01% | 1449 |
|
|
2020
Q4 | $0 | Sell |
21,618
-427
| -2% | -$21.2K | ﹤0.01% | 8233 |
|
|
2020
Q3 | $0 | Buy |
+22,045
| New | +$952K | ﹤0.01% | 7677 |
|
|
2020
Q2 | – | Sell |
-10,834
| Closed | -$520K | – | 7490 |
|
|
2020
Q1 | $457K | Sell |
10,834
-16,020
| -60% | -$660K | ﹤0.01% | 2693 |
|
|
2019
Q4 | $1.15M | Sell |
26,854
-40,966
| -60% | -$1.78M | ﹤0.01% | 1968 |
|
|
2019
Q3 | $2.44M | Buy |
67,820
+34,775
| +105% | +$1.05M | 0.01% | 1186 |
|
|
2019
Q2 | $883K | Sell |
33,045
-35,136
| -52% | -$898K | ﹤0.01% | 2020 |
|
|
2019
Q1 | $1.83M | Buy |
68,181
+33,805
| +98% | +$789K | 0.01% | 1442 |
|
|
2018
Q4 | $555K | Sell |
34,376
-697
| -2% | -$13.5K | ﹤0.01% | 2120 |
|
|
2018
Q3 | $728K | Buy |
35,073
+9,525
| +37% | +$150K | ﹤0.01% | 2207 |
|
|
2018
Q2 | $390K | Buy |
+25,548
| New | +$456K | ﹤0.01% | 2713 |
|
|
2018
Q1 | – | Sell |
-10,077
| Closed | -$279K | – | 6013 |
|
|
2017
Q4 | $303K | Sell |
10,077
-11,149
| -53% | -$357K | 0.01% | 989 |
|
|
2017
Q3 | $799K | Sell |
21,226
-49,457
| -70% | -$1.61M | 0.03% | 453 |
|
|
2017
Q2 | $1.97M | Buy |
70,683
+24,992
| +55% | +$745K | 0.09% | 183 |
|
|
2017
Q1 | $1.57M | Buy |
45,691
+41,683
| +1,040% | +$1.47M | 0.07% | 258 |
|
|
2016
Q4 | $115K | Sell |
4,008
-18,307
| -82% | -$484K | 0.01% | 1417 |
|
|
2016
Q3 | $709K | Sell |
22,315
-1,775
| -7% | -$60.2K | 0.05% | 367 |
|
|
2016
Q2 | $781K | Buy |
24,090
+21,494
| +828% | +$719K | 0.05% | 360 |
|
|
2016
Q1 | $72K | Sell |
2,596
-5,947
| -70% | -$130K | 0.01% | 1626 |
|
|
2015
Q4 | $304K | Buy |
8,543
+6,517
| +322% | +$230K | 0.02% | 638 |
|
|
2015
Q3 | $66K | Buy |
2,026
+1,004
| +98% | +$41.8K | ﹤0.01% | 1764 |
|
|
2015
Q2 | $42K | Buy |
+1,022
| New | +$39.6K | ﹤0.01% | 1812 |
|
Other funds holding ACAD
BBA
RI
PAI
Simplex Trading's ACAD Position: Q1 2026 in Review
Simplex Trading sold out of Acadia Pharmaceuticals (ACAD) in Q1 2026, closing a stake of 2,435 shares — an estimated $58.2K sold.
Simplex Trading first reported a position in ACAD in Q2 2015 and held it in 37 quarters. The position peaked at $2.44M in Q3 2019. 343 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.
- Simplex Trading reported no remaining Acadia Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 2,435 Acadia Pharmaceuticals shares in Q1 2026, an estimated $58.2K.
- Simplex Trading first reported a position in Acadia Pharmaceuticals in Q2 2015 and held it in 37 quarters.
- Simplex Trading's Acadia Pharmaceuticals position peaked at $2.44M in Q3 2019.
- 343 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.